A comparison of anion-exchange and steric-exclusion HPLC assays of mouse plasma lipoproteins

Journal of Lipid Research

Volumn 46, Issue 8, 2005, Pages 1786-1795

  Neyer, Jonathan ^b   Espinoza, Christian ^b   Luppen, Luppe ^b   Dohety, Terence M ^b   Tripathi, Subhash C ^b   Uzui, Hiroyasu ^b   Tripathi, Pinky V ^b   Lee, Gerald ^b   Shah, Prediman K ^b   Rajavashisth, Tripathi B ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b NONE

Author keywords

Cholesterol measurement; High density lipoprotein; High performance liquid chromatography; Lipoproteins; Low density lipoprotein; Very low density lipoprotein

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ANION EXCHANGE; ANION EXCHANGE CHROMATOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SIGNAL NOISE RATIO; STERIC EXCLUSION HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STORAGE; ULTRACENTRIFUGATION; VARIANCE;

ANIMALS; ANION EXCHANGE RESINS; CHOLESTEROL; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; METHODS; MICE; PRESERVATION, BIOLOGICAL; SPECIMEN HANDLING;

EID: 23244462781     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.D500002-JLR200     Document Type: Article

References (23)

1. American Heart Association. 2003. Heart Disease and Stroke Statistics-2004 Update. American Heart Association, Dallas, TX.
2. Tunstall-Pedoe, H., K. Kuulasmaa, P. Amouyel, D. Arveiler, A. M. Rajakangas, and A. Pajak. 1994. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 90: 583-612.
3. Murray, C. J., and A. D. Lopez. 1997. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 349: 1498-1504.
4. World Health Organization. 1999. The World Health Report. Making a Difference. World Health Organization, Geneva, Switzerland.
5. Kannel, W. B. 2000. Epidemiologic contributions to preventive cardiology and challenges for the twenty-first century. In Preventive Cardiology. N. D. Wong, H. R. Black, and J. M. Gardin, editors. McGraw-Hill, New York. 3-20.
6. Gordon, T., and W. B. Kannel. 1971. Premature mortality from coronary heart disease: the Framingham Study. J. Am. Med. Assoc. 215: 1617-1625.
7. Keys, A. 1980. Seven Countries. A Multivariate Analysis of Death and Coronary Heart Disease. Harvard University Press, Cambridge, MA.
8. Kannel, W. B., W. P. Castelli, and T. Gordon. 1979. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study. Ann. Intern. Med. 90: 85-91.
9. Libby, P. 2002. Inflammation in atherosclerosis. Nature. 420: 868-874.
10. Glass, C. K., and J. L. Witztum. 2001. Atherosclerosis. The road ahead. Cell. 104: 503-516.
11. Steinberg, D. 2002. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8: 1211-1217.
12. Libby, P. 2001. The vascular biology of atherosclerosis. In A Textbook of Cardiovascular Medicine. 6th edition. E. Braunwald, D. P. Zipes, and P. Libby, editors. W. B. Saunders, Philadelphia, PA. 995-1009.
13. Usui, S., M. Nakamura, K. Jitsukata, M. Nara, S. Hosaki, and M. Okazaki. 2000. Assessment of between-instrument variations in a HPLC method for serum lipoproteins and its traceability to reference methods for total cholesterol and HDL-cholesterol. Clin. Chem. 46: 63-72.
14. Yoshida, A., M. Naito, M. Kodama, and H. Nomura. 2001. Comparison of direct methods and HPLC for the measurement of HDL- and LDL-cholesterol with ultracentrifugation. J. Atheroscler. Thromb. 8: 84-90.
15. Yamaguchi, Y., M. Kunitomo, and J. Haginaka. 2002. Assay methods of modified lipoproteins in plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 781: 313-330.
16. Yamaguchi, Y., M. Kunitomo, and J. Haginaka. 1998. AE high-performance liquid chromatographic assay of plasma lipoproteins of rabbits, rats and mice. J. Chromatogr. B Biomed. Sci. Appl. 716: 57-64.
17. Yamaguchi, Y., S. Kagota, M. Kunitomo, and J. Haginaka. 1998. Evidence of modified lipoprotein in the plasma of Watanabe heritable hyperlipidemic rabbits by AE high-performance liquid chromatographic assay. Atherosclerosis. 139: 323-331.
18. Haginaka, J., Y. Yamaguchi, and M. Kunitomo. 2001. AE high-performance liquid chromatography assays of plasma lipoproteins and modified low-density lipoproteins using a ProtEx-DEAE column. J. Chromatogr. B Biomed. Sci. Appl. 751: 161-167.
19. Haginaka, J., Y. Yamaguchi, and M. Kunitomo. 1995. AE high-performance liquid chromatographic assay of plasma lipoproteins. Anal. Biochem. 232: 163-171.
20. Garber, D., K. Kulkarni, and G. M. Anantharamaiah. 2000. A sensitive and convenient method for lipoprotein profile analysis of individual mouse samples. J. Lipid Res. 41: 1020-1026.
21. Jiao, S., T. G. Cole, R. T. Kitchens, B. Pfleger, and G. Schonfeld. 1990. Genetic heterogeneity of plasma lipoproteins in the mouse: control of low density lipoprotein particle sizes by genetic factors. J. Lipid Res. 31: 467-477.
22. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
23. Camus, M. C., M. J. Chapman, P. Forgez, and P. M. Laplaud. 1983. Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus. J. Lipid Res. 24: 1210-1228.